Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish

CREB engages C/EBPδ to initiate leukemogenesis

(2016) C Tregnago et al.   LEUKEMIA

Overexpression of FLT3-ITD driven by spi-1 results in expanded myelopoiesis with leukemic phenotype in zebrafish

(2016) J-W Lu et al.   LEUKEMIA

Genetic alterations and their clinical implications in older patients with acute myeloid leukemia

(2016) C-H Tsai et al.   LEUKEMIA

c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish

(2016) W Liu et al.   LEUKEMIA

Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer

(2015) Dingmiao Wang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis

(2015) Ling Li et al.   NEUROPATHOLOGY

Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma

(2015) Ning Lu et al.   TUMOR BIOLOGY

SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients

(2015) Guo-Dong Song et al.   TUMOR BIOLOGY

A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells

(2015) Guanhua Song et al.   Oncotarget

SOX4 is associated with poor prognosis in cholangiocarcinoma

(2014) Weishan Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Functions of flt3 in zebrafish hematopoiesis and its relevance to human acute myeloid leukemia

(2014) B.-L. He et al.   BLOOD

Sox4you: A New Player in C/EBPα Leukemia

(2013) Tsz Kan Fung et al.   CANCER CELL

Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia

(2013) Hong Zhang et al.   CANCER CELL

Transcription Factors SOX4 and SOX11 Function Redundantly to Regulate the Development of Mouse Retinal Ganglion Cells

(2013) Ying Jiang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia

(2013) H-A Hou et al.   LEUKEMIA

Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer

(2013) Chun-Mao Lin et al.   PLoS One

SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial–mesenchymal transition in vitro

(2013) L Wang et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Sox4 cooperates with CREB in myeloid transformation

(2012) S. Sandoval et al.   BLOOD

Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis

(2012) Seyed Mehdi Jafarnejad et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Clinicopathological significance of SOX4 expression in primary gallbladder carcinoma

(2012) Chengguo Wang et al.   Diagnostic Pathology

PML-RAR  co-operates with Sox4 in acute myeloid leukemia development in mice

(2012) N. Omidvar et al.   HAEMATOLOGICA

The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe?

(2012) S J Vervoort et al.   ONCOGENE

Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia

(2011) G. Aue et al.   BLOOD

Identification and characterization of Hoxa9 binding sites in hematopoietic cells

(2011) Y. Huang et al.   BLOOD

Common and Overlapping Oncogenic Pathways Contribute to the Evolution of Acute Myeloid Leukemias

(2011) B. T. Kvinlaug et al.   CANCER RESEARCH

Effects of the NUP98–DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif

(2010) E R Yassin et al.   LEUKEMIA

CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia

(2010) T-C Lin et al.   LEUKEMIA

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

(2009) B. J. Wouters et al.   BLOOD

Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’

(2009) H-A Hou et al.   BRITISH JOURNAL OF CANCER

The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer†

(2009) Pedro P. Medina et al.   HUMAN MOLECULAR GENETICS

Twenty Sox, twenty years

(2009) Vincent Harley et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia

(2007) Hsin-An Hou et al.   LEUKEMIA RESEARCH